Saturday, February 8, 2025

CATEGORY

Abbott

Abbott Achieves First-In-Human Leadless Left Bundle Branch Pacing

Key TakeawaysAVEIR CSP system offers synchronized pacing via high-frequency electrical impulses. Leadless design minimizes invasive procedures and associated risks. FDA’s Breakthrough Device Designation...

Abbott Launches New TAVI System to Enhance Aortic Stenosis Treatment

Key TakeawaysExpands Abbott’s structural heart portfolio with a new TAVI option Designed for compatibility with AI-guided procedural enhancements Targets a growing demographic with...

Abbott Boosts Clinical Trial Diversity Through Strategic Partnerships and New Initiatives

parnABBOTT PARK, Ill. – In its third year, Abbott has intensified efforts to diversify clinical trials by releasing 'Advancing Diversity in Clinical Trials,' a...

Amplatzer Amulet Outperforms Watchman in Long-Term AFib Treatment

Abbott has unveiled five-year data demonstrating that the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder significantly reduces the necessity for prolonged blood-thinning medication in...

Technological Innovations Propel Diabetes Care Devices Market to $17.87 Billion by 2032

The diabetes care devices market is witnessing a remarkable surge, driven by technological innovations and increased awareness of diabetes management. With the market set...

Medtronic Pushes Boundaries with FDA Approval of Innovative Mapping and Ablation System

In a significant advancement for cardiac care, Medtronic plc, a leader in healthcare technology, has received FDA approval for its Affera Mapping and Ablation...

Abbott Launches Groundbreaking TEAM-HF Trial to Enhance Heart Failure Treatment

In an effort to reshape the landscape of heart failure treatment, Abbott has embarked on an ambitious clinical trial, TEAM-HF, aimed at identifying patients...

Japan’s Diabetes Device Market Soars with Technological Innovations and Government Support

Japan's diabetes device market is experiencing robust growth, driven by technological innovations and strategic government interventions. As the nation grapples with an increasing diabetic...

Hormone Replacement Therapy Market Thrives with Innovative Drug Delivery Systems

The Hormone Replacement Therapy (HRT) market is experiencing robust growth, driven by an increasing demand for advanced therapies and innovative drug delivery systems. With...

Abbott Pushes Forward with New Milestones in Electrophysiology

Abbott is making significant strides in the field of electrophysiology with its latest advancements in pulsed field ablation (PFA) technologies, reflecting the company’s commitment...

Abbott Advances Pulsed Field Ablation Studies and Launches New Cardiac Mapping Technology

Key TakeawaysAbbott completes enrollment in the VOLT-AF study for its Voltâ„¢ Pulsed Field Ablation (PFA) system and launches the FOCALFLEX trial to test...

Abbott and Big Ten Conference Launch Landmark Nationwide Blood Donation Competition to Address Critical U.S. Shortage

Key TakeawaysAbbott and the Big Ten Conference kick off "The We Give Blood Drive," a nationwide blood donation competition across 18 universities to...

Abbott Partners with Seed Global Health to Revolutionize Maternal and Child Healthcare in Malawi

Key TakeawaysAbbott and Seed Global Health join forces to establish a Maternal Health Center of Excellence in Malawi, addressing critical gaps in healthcare...

Abbott Initiates Clinical Study to Evaluate Deep Brain Stimulation for Severe Depression

Key TakeawaysAbbott has launched a pivotal clinical trial called TRANSCEND to evaluate its deep brain stimulation (DBS) system for managing treatment-resistant depression (TRD). ...

Recall of Abbott FreeStyle Libre 3 Receives Class I Designation from FDA

Key TakeawaysAbbott issued a recall for its FreeStyle Libre 3 continuous glucose monitoring (CGM) sensors in July 2024 due to incorrect glucose readings...

Latest news